India to thwart attempt by MNCs to get generics tagged spuri

NEW DELHI: With multinational pharmaceutical companies approaching the World Health Organisation (WHO) once again to formulate guidelines which would put generic versions of patented drugs in the same bracket as unsafe and ineffective drugs, India has geared up to protect its generic (off-patent drugs) industry

Read more »

Fake drugs a bitter pill for India

NEW DELHI - Two recent reports by international health organizations have highlighted the disquieting magnitude of the counterfeit drugs market in India

Read more »

Fake Drugs big business in India – UPI.com


Read more »

India raise concern over WHO’s failure to replace IMPACT w

India has raised strong concern over the delay in setting up a working group by the World Health Organisation to address the problems of counterfeit and substandard medicines and adopt changes in the policy, instead of leaving the task with controversial International Medical Products Anti-Counterfeiting Taskforce (IMPACT)

Read more »